The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction

Table 1

The comparison of characteristics and sST2 level between controls and subjects with STEMI.

Characteristics	Controls,	Subjects with STEMI,	value
Demography
Age (years), mean ± SD	61.0 ± 2.9	58.2 ± 8.5	0.30
Male sex, (%)	8 (80.0)	76 (80.0)	0.68
Body mass index, mean ± SD	26.3 ± 2.8	24.2 ± 2.8	0.06
Risk factors
Diabetes mellitus, (%)	5 (50.0)	28 (29.5)	0.18
Hypertension, (%)	10 (100.0)	55 (57.9)	<0.01
Current smoking, (%)	2 (20.0)	50 (52.6)	0.12
Clinical parameters
Systolic b.p (mmHg), mean ± SD	132.0 ± 17.5	128.9 ± 26.4	0.72
Diastolic b.p (mmHg), mean ± SD	73.0 ± 9.7	78.9 ± 16.4	0.41
Heart rate (bpm), mean ± SD	73.0 ± 9.7	76.1 ± 18.5	0.60
Laboratory examination
Hemoglobin (g/dL), mean ± SD	13.4 ± 1.8	13.8 ± 1.8	0.48
Leucocytes (10^3/mm^3), mean ± SD	8.3 ± 2.8	12.8 ± 3.2	<0.01
Platelets (10^3/mm^3), mean ± SD	283.5 ± 48.9	276.6 ± 97.7	0.83
Creatinine (mg/dL), mean ± SD	1.3 ± 0.4	1.3 ± 0.5	0.58
Glucose (mg/dL), mean ± SD	131.2 ± 41.1	181.5 ± 94.8	<0.01
sST2 (ng/mL), median (q1–q3)	28.5 (22.7–36.9)	152.1 (72.0–250.0)	<0.01

b.p = blood pressure; bpm = beat per minute; q1 = first quartile; q3 = third quartile; Mann–Whitney U test.